Crossref
Uptake of Extended Next‐Generation Sequencing and DPYD Testing in Metastatic Colorectal Cancer in Australia: A Multicentre, Real‐World Analysis
Asia-Pacific Journal of Clinical Oncology · 2026-11 · 22 (S6) · 21-21
DOI: 10.1111/ajco.70236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, online erschienen am 19.11.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Uptake of Extended Next‐Generation Sequencing and DPYD Testing in Metastatic Colorectal Cancer in Australia: A Multicentre, Real‐World Analysis. Asia-Pacific Journal of Clinical Oncology, 22(S6), 21-21. https://doi.org/10.1111/ajco.70236
Vancouver
Uptake of Extended Next‐Generation Sequencing and DPYD Testing in Metastatic Colorectal Cancer in Australia: A Multicentre, Real‐World Analysis. Asia-Pacific Journal of Clinical Oncology. 2026;22(S6):21-21. doi:10.1111/ajco.70236
BibTeX
@article{euvimed2026,
title = {Uptake of Extended Next‐Generation Sequencing and DPYD Testing in Metastatic Colorectal Cancer in Australia: A Multicentre, Real‐World Analysis},
journal = {Asia-Pacific Journal of Clinical Oncology},
year = {2026},
volume = {22},
number = {S6},
pages = {21--21},
doi = {10.1111/ajco.70236}
}
EUVIMED